This study was aimed to evaluate the role of ‰unarizine on gentamicin (GEM) induced nephrotoxicity in rat. Administration of GEM (40 mg/kg, s.c. for 10 consecutive days) signiˆcantly increased blood urea nitrogen (BUN), Nacetyl b-d-glucosaminidase (NAG), thiobarbituric acid reactive substances (TBARS) and total calcium whereas, decreased body weight, fractional excretion of sodium (FrNa), creatinine clearance (CrCl), reduced glutathione (GSH), mitochondrial cytochrome c oxidase (Cyt-C oxidase) and ATP levels resulting in nephrotoxicity. Further, ‰unarizine (100, 200 and 300 mmol/kg, p.o.) was administered to evaluate its renoprotective eŠect against GEM induced nephrotoxicity and the results were compared with cylcosporin A (CsA, 50 mmol/kg, p.o.). Flunarizine resulted in the attenuation of renal dysfunction and oxidative marker changes in rats subjected to GEM induced nephrotoxicity in a dose dependent manner. Medium and higher doses of ‰unarizine produced signiˆcant renal protective eŠect which was comparable to cyclosporin A. The results of this study clearly revealed that ‰unarizine protected the kidney against the nephrotoxic eŠect of GEM via mitochondrial permeability transition pore (MPTP) inactivation potential.
INTRODUCTION
Gentamicin (GEM) is widely applied in veterinary and human clinical practices for treatment of lifethreatening gram negative infections. 1, 2) GEM is considered an``obligatory nephrotoxin'' and even small doses have been reported by several authors to produce nephrotoxicity in man and animals. 3, 4) It is an aminoglycoside antibiotic that is still commonly used in the treatment of life-threatening infections. Their broad-spectrum activity, chemical stability and rapid bactericidal action have often made themˆrst-line drugs in a variety of clinical situations. 2, 5, 6) However, high concentrations of these antibiotics are known to be nephrotoxic. In some cases, this side eŠect is so severe that the use of the drug must be discontinued. It has been estimated that up to 30％ of the patients treated with aminoglycosides for more than 7 days showed some signs of nephrotoxiciy. 7) GEM induced nephrotoxicity leads to disability in the excretion of the daily waste products (i.e., urea, uric acid, creatinine etc.) in the urine. 1, 8) GEM has shown increase in the generation of reactive oxygen species (ROS) such as H 2 O 2 orOH in cellular systems in both in vitro and in vivo studies. 8,9 11) Generally, ROS and cytotoxins can cause cell death by necrosis or apoptosis, often in a dose-dependent manner. Mitochondria can play a vital role in both apoptosis and necrosis. 12 15) The opening of mitochondrial permeability transition pores (MPTP) due to ROS and cytokines wasˆrst described in necrotic cell death. During the process of opening of MPTP, a cyclosporin A (CsA)-sensitive pore is opened resulting in a swelling of mitochondria and destruction of the outer mitochondrial membrane. 14,16 18) Mitochondrial Ca 2＋ overload leads to mitochondrial membrane permeability transition, which is associated with the opening of a MPTP. 19, 20) The attack of ROS to membrane protein thiols produces cross-linking reaction that may open membrane pores upon Ca 2＋ binding. 21) It is interesting to note that CsA is the most potent mitochondrial permeability transition inhibitor described till date. 18) Pharmacologically, many agents have been reported to attenuate GEM induced nephrotoxicity in experimental animals. 8,22 24) Recently, various natural antioxidant were focused on the prevention of nephrotoxicity. 9, 23, 25, 26) Clinically, ‰unarizine has been widely used to treat vertigo, 27) migraine, 28) epilepsy 29) and tinnitus. 30) Some of the studies sug-gested the possibility that ‰unarizine may act directly on mitochondria and result in closing of MPTP. 31) Furthermore, it reduced the mitochondrial swelling and lipid peroxidation induced by Fe 2 SO 4 and ascorbic acid. 32) No drug treatment has been shown to limit the progression of renal damage and/or speed up recovery from nephrotoxin induced renal failure.
The clinical pattern of GEM induced kidney damage has been studied extensively in both man and animals. 3, 4) Recently, some factors have been identied to increase the risk of aminoglycoside induced nephrotoxicity that cannot be modiˆed readily by the clinician (e.g., sex, obesity, preexisting liver or renal diseases and underlying diseases) and factors that the clinician may be able to modify (i.e., drug dosage/interval/duration, speciˆc aminoglycoside, hypokalaemia, hypomagnesaemia, metabolic acidosis, volume depletion and concurrent medications). 33 35) However, there is no unanimity in the literature regarding the possible mechanism of action and factors that can modulate the GEM induced nephrotoxicity. Hence, in the present study it is theˆrst attempt to explore the role of ‰unarizine on GEM induced nephrotoxicity via inactivation of MPTP.
MATERIALS AND METHODS

Animal
Male Sparque Dawley rats (180 250 g) were procured from the Panjab University, Chandigarh. The animals were housed under standard laboratory conditions of temperature relative humidity with free access to food (Hindustan Lever Products, Kolkata, India) and water ad libitum. A 12 h light-dark cycle was maintained throughout the experimental protocol. An acclimatization period of 7 days was allowed for the rats before experimentation. and 1,1,3,3-tetra methoxy propane (Loba Chem, Mumbai) were procured for the present study. GEM was obtained as a gift sample from Ranbaxy Pharmaceuticals, Mumbai. All the reagents used in the present study were of analytical grade.
Experimental Design Six groups, each comprising of six rats (n＝6), were included in the acute renal injury. Group I (Normal control group): Normal saline (0.5 ml, p.o.) was given for 10 (day 0 9) consecutive days. Group II (GEM control group): Gentamicin (40 mg/kg, s.c.) was given for 10 consecutive days. Group III: Rats were subjected to administration of cyclosporin A (CsA, 50 mmol/kg, p.o.) before one hour of the each GEM injection for 10 consecutive days. Group IV VI: Rats were subjected to administration of ‰unarizine (100, 200 and 300 mmol /kg, p.o.) before one hour of the each GEM injection for 10 consecutive days.
In all the groups rats were weighed, before (day 0) and after (day 10) drug administration.
Biochemical Estimation Rats were placed in the metabolic cages (on day 9) and urine samples were collected over the period of 24 hours. Rats were anesthetized with thiopental sodium (35 mg/kg, i.p., on day 10). Blood was collected from the inferior vena cava in plain plastic tubes with and without anticoagulant (sodium citrate), left to stand at 4°C for 1 h, and centrifuged at 900 g at 5°C for 15 min to separate serum and plasma respectively. The rats were sacriˆced with euthanasia. The kidneys were removed from the rats and washed with ice-cold saline. A small piece from the left kidney wasˆxed in 10％ buŠered formalin. The medullary portion of the kidney was homogenized in ice-cold saline to produce 10％ (w/v) tissue homogenate.
Evaluation of Renal Function
Blood urea nitrogen (BUN) was estimated in blood sample whereas, N-acetyl b-d-glucosaminidase (NAG) was estimated in urine sample by using standard diagnostic kits (Span Diagnostics, Gujarat, India). Abnormal changes in BUN level served as an indicator of impaired glomerular function whereas, changes in NAG level served as a speciˆc indicator of tubular damage. The fractional excretion of sodium (FrNa ＝ Sodium Urine / Sodium Plasma × Creatinine Plasma / Creatinine Urine ×100) and the creatinine clearance (CrCl＝Creatinine Urine /Creatinine Plasma ×Urine Volume / time) were measured as an index of renal function.
Estimation of Total Tissue Protein Content
Renal tissue protein content was estimated according to the method of Lowry et al. 36) using bovine serum albumin (BSA) as a standard. The absorbance was determined spectrophotometrically at 750 nm.
Estimation of Tissue TBARS Levels
Estimation of lipid peroxidation was performed by measuring the thiobarbituric acid reactive substances (TBARS) by the method of Okawa et al. 37) A standard calibration curve was prepared by using 1 10 nM of 1,1,3,3-tetra methoxy propane. The concentration was expressed in terms of nanomoles of TBARS per mg of protein.
Estimation of Tissue Reduced Glutathione The reduced glutathione (GSH), content in the renal tissue was estimated using method of Ellman. 38) A standard curve was plotted using 5 50 mmol of reduced form of glutathione. The concentration was expressed in terms of micromole of GSH per mg of protein.
Estimation of Total Calcium
Total calcium levels were estimated in the renal tissue as described by Severnghaus and Ferrebee. 39) Brie‰y, the renal tissue homogenate was mixed with 1 ml of trichloroacetic acid (4％) in the ice-cold condition and centrifuged at 1500×g for 10 min. The clear supernatant was used for estimating the total calcium levels by atomic emission spectroscopy at 556 nm.
Preparation of Mitochondria Renal mitochondria was isolated from rat kidney tissue as described by method of Stephan et al. 40) with slight modiˆca-tion of Long et al. 41) Brie‰y, tissues were washed with saline, weighed and put into ice-cold isolation buŠer containing 0.25 M sucrose, 10 mM Tris base, 0.5 mM EDTA (pH 7.4). Tissues were homogenized in 2.5 volume of isolation buŠer. The homogenate was adjusted to 8 volumes with isolation buŠer and centrifuged at 1000×g for 4 min. The supernatant fraction was decanted and saved. The pellet was washed once with 2 volume of isolation buŠer. The supernatant fractions were combined and centrifuged at 10000×g for 4 min. The mitochondrial pellet was washed twice with isolation buŠer. All the above mentioned operations were carried out at 4°C. An aliquot was used for the estimation of mitochondria respiration chain function (i.e., cytochrome c oxidase activity) and adenosine triphosphate (ATP) content.
Estimation of Cytochrome C Oxidase Activity and ATP Content
The activity of cytochrome c oxidase (Cyt-C oxidase; as an index of respiratory marker enzymes) was measured according to the method of Rustin et al. 42) The enzymatic activity was measured by following the decrease in absorbance of reaction mixture at 550 nm with 580 nm as reference wavelength (e＝19.1 mM -1 cm -1 ). The activity of cytochrome c oxidase was measured at 25°C for 10 min and activity was expressed in terms of nM of cytochrome c oxidase per minute per mg of protein. Adenosine triphosphate was measured by using HPLC technique as described method of Paroni et al. 43) and Vecchi et al. 44) after neutralization of acid supernatant with sodium bicarbonate. The content of ATP was expressed in terms of nM of ATP per mg of protein.
Statistical Analysis All the results were expressed as mean±standard error of means (S.E.M). The data of all biochemical estimation was statistically analyzed by one-way ANOVA followed by Tukey's multiple range tests by using Sigmastat Version-2.0 software. The p-value＜0.05 was considered to be statistically signiˆcant.
RESULT EŠect of Flunarzine on Body Weight
The results demonstrated that GEM caused a marked decrease in total body weight as compared to normal control group. However, pretreatment with ‰unari-zine (200 and 300 mmol/kg) and CsA had attenuated this change as compared to GEM treated group (Fig.  1) .
EŠect of Flunarzine on Renal Functional Markers
The results demonstrated that GEM caused a marked increase in blood urea nitrogen (BUN), urinary N-acetyl b-d-glucosaminidase (NAG) and decrease in fractional sodium excretion (FrNa) and cretenine clearance (CrCl) as compared to sham control group. However, pretreatment with medium and high dose of ‰unarizine had signiˆcantly improved this alteration in the serum and urinary biomarker changes which were comparable to that of normal control and CsA treated groups ( Table 1) .
EŠect of Flunarzine on Tissue and Mitochondrial Biomarker Changes
The results demonstrated that GEM caused a marked increase in tissue thiobarbituric acid reactive substances (TBARS) and total calcium whereas, decrease in reduced glutathione (GSH), mitochondrial cytochrome c oxidase (Cyt-C oxidase) and ATP levels as compared to normal control group whereas, pretreatment with medium and high dose of ‰unarizine (200 and 300 mmol/kg) had Values are mean±S.E.M. of 6 animals. a p＜0.05, as compared to normal control group; b p＜0.05, ‰unarizine pretreated groups as compared to GEM control group, in parenthesis indicated the dose of CsA and ‰unarizine in mmol/kg. BUN, Blood urea nitrogen; Cr, Creatinine; NAG, N-acetyl b-d-glucosaminidase; FrNa, Fractional excretion of sodium; CrCl, Creatinine clearance. Values are mean±S.E.M. of 6 animals. a p＜0.05, as compared to normal control group; b p＜0.05, ‰unarizine pretreated groups as compared to GEM control group, in parenthesis indicated the dose of CsA and ‰unarizine in mmol/kg. TBARS, Thiobarbituric reactive substances; GSH, Reduced glutathione; Cyt-C oxidase, cytochrome c oxidase; ATP, Adenosine triphosphate.
signiˆcantly ameliorated GEM induced renal tissue biomarkers change which were comparable to that of normal control and CsA treated groups ( Table 2) .
DISCUSSION
In this study, we demonstrated that ‰unarazine (200 and 300 mmol/kg) administration had signiˆcantly reduced serum BUN, urinary NAG, tissue TBARS and total calcium whereas, increased body weight, FrNa, CrCl, GSH, mitochondrial cytochrome c oxidase (Cyt-C oxidase) and ATP levels resulting in the attenuation of renal dysfunction in rats subjected to GEM induced nephrotoxicity. This is theˆrst report, as far as we are aware, on the eŠect of ‰unari-zine in GEM induced nephrotoxicity via inactivation of MPTP opening.
Administration of GEM has been resulted in the body weight reduction along with renal dysfunction, which had also been reported in the previous studies. 10, 45) The reduction in body weight following GEM treatment may possibly be due to the injured renal tubules and the subsequent loss of the tubular cells to reabsorb water, leading to dehydration and loss of body weight. The blood, urine and renal tissue sample analysis has conˆrmed that GEM caused signiˆcant increase in the serum BUN, urinary NAG and tissue total calcium levels whereas, it decreased the FrNA and CrCl levels. GEM induced nephrotoxicity involves generation of reactive oxygen species (ROS). 25) GEM has been reported to inhibit the activity of antioxidant systems (i.e., superoxide dismutase, catalase, glutathione peroxidase) and deplete the cellular thiols and membrane lipid products. 46 48) Oxidative stress in kidney plays an important role in GEM induced renal damage as well as several antioxidants and thiol compounds have been shown to possess protective action against GEM induced nephrotoxicity. 1, 25, 49) Calcium ions play role in diverse models of cell death induced by ROS or toxins. 20, 50) Further, GEM is known to possess MPTP opening action. 19) GEM induced renal damage associated with renal mitochondrial dysfunction, oxidative stress and modulation of functional marker such as BUN, NAG, TBARS and GSH are well documented. 51, 52) In physiological condition, mitochondrial functions are an index of uptake of oxygen, calcium handling, production of ATP, activity of the citrate cycle and the regulation of respiratory chain. In pathological condition, mitochondrial lipid peroxidation is well documented to alteration of membrane integrity and permeability of mitochondrial including sarcolemmal membranes. 53, 54) In pathological condition, mitochondrial lipid peroxidation alters membrane integrity and permeability of mitochondrial including sarcolemmal membranes. 53, 54) These alterations of GEM result in modulation of mitochondrial function (i.e., calcium overload, phospholipase activation, inhibition of respiratory chain function etc.) leads to ATP depletion and lipid peroxidation crucially irreversible injury. 54, 55) Many authors reported that cyclosporin A (CsA) is a very potent selective inhibitor of MPTP due to its binding ability with cyclophilin D protein of MPTP. 54) Therefore, in our present work cyclosporine was taken as reference drug to compare the eŠect of ‰unarizine in GEM induced acute renal failure. Further, ‰unarizine is known to have free radical scavenging activity, 50, 56, 57) and it also possesses the property of decreasing lipid peroxidation process as well as inactivation of MPTP channel opening. 31, 50) Moreover, it has been reported that mitochondrial calcium overload induced lethal MPTP opening, and ‰unarizine (calcium channel blocker) was found to attenuate this eŠect in the present study. Flunarizine has also shown ameliorative eŠect on GEM induced biochemical changes in rats. Therefore, it can be concluded that dual (calcium channel blocker and direct MPTP inactivation) roles of ‰unarizine possess the renoprotective eŠect on GEM induced nephrotoxicity.
